fluoxetine and buspirone

fluoxetine has been researched along with buspirone in 101 studies

Research

Studies (101)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.99)	18.7374
1990's	40 (39.60)	18.2507
2000's	27 (26.73)	29.6817
2010's	28 (27.72)	24.3611
2020's	5 (4.95)	2.80

Authors

Authors	Studies
Baldessarini, RJ; Booth, RG; Charifson, PS; Kula, NS; McPhail, AT; Myers, AM; Owens, CE; Wyrick, SD	1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ	1
Sen, S; Sinha, N	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Caliendo, G; Capasso, R; Ciano, A; Corvino, A; Di Vaio, P; Fiorino, F; Frecentese, F; Izzo, AA; Kędzierska, E; Kotlińska, JH; Magli, E; Massarelli, P; Orzelska-Gòrka, J; Perissutti, E; Rossi, I; Saccone, I; Santagada, V; Severino, B	1
Hart, LL; Maruno, CA	1
Ellen, S; Judd, F; Norman, T	1
Chick, ME	1
Hawkins, JW	1
Grady, TA; L'Heureux, F; Murphy, DL; Pigott, TA	1
Campeas, R; Fallon, BA; Feerick, J; Gitow, A; Hollander, E; Liebowitz, MR; Saoud, JB; Schneier, FR; Street, L; Welkowitz, LA	1
Bakish, D	1
Janowsky, DS; Overstreet, DH; Rezvani, AH	1
Alessi, N; Bos, T	1
Baer, L; Buttolph, L; Jenike, MA	1
Li, ET; Luo, SQ; Ransom, T	1
Calabrese, JR; Markovitz, PJ; Stagno, SJ	1
Masand, P; Tanquary, J	1
Metz, A	1
Bodkin, JA; Teicher, MH	1
Lauterbach, EC	1
Abbas, S; Chandra, PS; Srivastava, M	1
Overall, KL	1
Ellison, JM; Stanziani, P	1
Tanquary, J	1
Joffe, RT; Schuller, DR	1
Goodman, WK; McDougle, CJ; Price, LH	1
Goudemand, M; Lebert, F; Pasquier, F; Petit, H	1
Sternlicht, HC	1
Bernstein, SE; Grady, TA; Hill, JL; L'Heureux, F; Murphy, DL; Pigott, TA	1
Meert, TF	1
Lucki, I	1
Katz, G; Nijhawan, PK; Winter, S	1
Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH	1
Brown, J; Del Boca, FK; Korner, PF; Kranzler, HR	1
Cistarelli, JM; Gobert, A; Millan, MJ; Rivet, JM	1
Callahan, PM; Cunningham, KA	1
Dawson, LA; Nguyen, HQ	1
Bourin, M; Redrobe, JP	1
Costall, B; Neill, JC; Wilson, AW	1
Trappler, B	1
Mikkelsen, HU; Thomsen, PH	1
Cistarelli, L; Gobert, A; Melon, C; Millan, MJ; Rivet, JM	1
Baschirotto, A; Borsini, F; Brambilla, A; Grippa, N	1
Bancroft, J; Kim, Y; Michelson, D; Targum, S; Tepner, R	1
Andreev, BV; Kudriashova, MF	1
Carlson, EC; de Felipe, C; Harrison, T; Hunt, S; Oates, B; Owen, S; Rupniak, NM; Seward, E; Wheeldon, A	1
Woods, SW	1
Terao, T	1
Appelberg, BG; Koskinen, TE; Mehtonen, OP; Muhonen, TT; Naukkarinen, HH; Syvälahti, EK	1
Barreau, S; Belzung, C; Calatayud, F; Le Guisquet, AM	1
Katoh, S; Nakamura, M; Nisijima, K; Yoshino, T; Yui, K	1
Eaton, LA; Spinella, M	1
Ferris, CF; King, JA; Messenger, T	1
Chrousos, GP; Gabry, KE; Gold, PW; McCann, SM; Mostafa, RM; Negrao, AB; Rice, KC; Sternberg, E; Webster, EL	1
Liang, JH; Liu, RK; Sun, HL; Wang, XH; Ye, XF; Zheng, JW	1
Onder, E; Tural, U	1
Fernández-Pérez, S; Pache, DM; Sewell, RD	2
Pan, WJ; Song, HR; Wang, F; Wang, YL; Wu, CF; Yang, JY	1
De Petrillo, PB; Dupuy, AM; Fontenot, MB; Higley, JD; Lynch, CR; Padgett, EE	1
Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM	1
de Bortoli, VC; Nogueira, RL; Zangrossi, H	1
Barsvári, B; Haller, J; Levay, G; Leveleki, C; Mikics, E; Soproni, K; Sziray, N	1
Antkowiak, R; Ciesielski, R; Komorowska, R; Rajewski, A; Rybakowski, F; Slopien, A	1
McNaughton, N; Munn, RG	1
Fragala, MR; Holmes, TF; Sabaawi, M	1
Jiang, Z; Shang, J; Wang, W; Zhang, H; Zhang, L	1
Benno, RH; Burke, TF; Daws, LC; Gould, GG; Hensler, JG; Onaivi, ES	1
Ardıç, UA; Gökben, S; Serdaroğlu, G	1
Birgandy, M; Jariani, M; Marzban, A; Nazari, H; Yari, F	1
Araújo, J; Benzecry, R; Crespo-Lopez, ME; de Jesus Oliveira Batista, E; Herculano, AM; Lima, MG; Maximino, C; Puty, B; Renata de Matos Oliveira, K	1
Farajnia, S; Haddadi, R; Nayebi, AM; Sharifi, H	1
Bernardez-Vidal, M; Frick, LR; Hocht, C; Rapanelli, M; Zanutto, BS	1
Dogaru, MT; Gáll, Z; Kolcsar, M	1
Bonan, CD; Lara, DR; Piato, AL; Schaefer, IC; Siebel, AM; Vianna, MR	1
Akça, ÖF; Çolak Sivri, R	1
Butkevich, IP; Mikhailenko, VA	2
Borns-Weil, S	1
Ahmadi, SA; Haddadi, R; Sabahi, M	1
Butkevich, IP; Mikhailenko, VA; Vershinina, EA	1
Alam, M; Edgerton, VR; Gerasimenko, Y; Jin, B; Lu, DC; Roy, RR; Tierno, A; Zhong, H	1
Aswar, M; Aswar, U; Shende, H	1
Hillhouse, TM; Olson, R; Partridge, KJ	1

Reviews

8 review(s) available for fluoxetine and buspirone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Buspirone in obsessive-compulsive disorder. The Annals of pharmacotherapy, 1992, Volume: 26, Issue:10 Topics: Adult; Buspirone; Clinical Trials as Topic; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder	1992
Anesthetic implications for the surgical patient prescribed psychotropic medications. CRNA : the clinical forum for nurse anesthetists, 1992, Volume: 3, Issue:3 Topics: Anesthetics; Buspirone; Cardiovascular Diseases; Drug Interactions; Fluoxetine; Humans; Psychotropic Drugs	1992
The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry, 1993, Volume: 26 Suppl 1 Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline	1993
Serotonin receptor specificity in anxiety disorders. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 6 Topics: Anxiety Disorders; Buspirone; Fluoxetine; Humans; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors	1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder. Drug safety, 1996, Volume: 15, Issue:2 Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan	1996
Pharmacoeconomic studies of antidepressants: focus on venlafaxine. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2000
Drug-induced akathisia: subjective experience and objective findings. Military medicine, 1994, Volume: 159, Issue:4 Topics: Akathisia, Drug-Induced; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Buspirone; Fluoxetine; Humans; Lithium; Risk Factors	1994

Trials

11 trial(s) available for fluoxetine and buspirone

Article	Year
Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:1 Topics: Buspirone; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales	1991
Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. The American journal of psychiatry, 1990, Volume: 147, Issue:6 Topics: Adult; Buspirone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Prospective Studies; Receptors, Serotonin	1990
An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. The Journal of clinical psychiatry, 1993, Volume: 54, Issue:7 Topics: Adult; Ambulatory Care; Buspirone; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors	1993
Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. The American journal of psychiatry, 1993, Volume: 150, Issue:5 Topics: Adult; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Placebos	1993
Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:8 Topics: Alcoholism; Anti-Anxiety Agents; Buspirone; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Patient Compliance; Riboflavin; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Ultraviolet Rays	1996
The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases. European child & adolescent psychiatry, 1999, Volume: 8, Issue:2 Topics: Adolescent; Adult; Buspirone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Severity of Illness Index	1999
Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. The American journal of psychiatry, 2000, Volume: 157, Issue:2 Topics: Adult; Amantadine; Anxiety Disorders; Buspirone; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Humans; Patient Selection; Placebos; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome	2000
Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:6 Topics: Adult; Aged; Ambulatory Care; Buspirone; Citalopram; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Finland; Fluoxetine; Humans; Male; Middle Aged; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Severity of Illness Index; Single-Blind Method; Treatment Outcome	2001
Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone. Journal of affective disorders, 2003, Volume: 76, Issue:1-3 Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Buspirone; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Time Factors; Treatment Outcome	2003
Temperament and character inventory and pharmacotherapeutic outcome in bulimia nervosa. Eating and weight disorders : EWD, 2005, Volume: 10, Issue:2 Topics: Adolescent; Adult; Assertiveness; Bulimia Nervosa; Buspirone; Female; Fluoxetine; Humans; Personality Assessment; Regression Analysis; Self Concept; Treatment Outcome	2005
Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine. Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:3 Topics: Adolescent; Adult; Buspirone; Female; Fluoxetine; Humans; Middle Aged; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Single-Blind Method; Treatment Outcome; Young Adult	2013

Other Studies

82 other study(ies) available for fluoxetine and buspirone

Article	Year
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. Journal of medicinal chemistry, 1994, Nov-25, Volume: 37, Issue:24 Topics: Animals; Ligands; Models, Molecular; Molecular Conformation; Receptors, sigma; Rodentia; Structure-Activity Relationship; Tetrahydronaphthalenes	1994
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results	2011
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
New 5-HT Bioorganic & medicinal chemistry, 2017, 10-15, Volume: 25, Issue:20 Topics: Animals; Binding Sites; Biological Assay; Ileum; Ligands; Maze Learning; Molecular Structure; Picolines; Protein Binding; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin Receptor Agonists	2017
Buspirone and fluoxetine in the treatment of OCD. The Australian and New Zealand journal of psychiatry, 1992, Volume: 26, Issue:4 Topics: Adult; Arousal; Buspirone; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder	1992
Nonsedating treatments for Alzheimer's patients with behavioral problems. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:3 Topics: Alzheimer Disease; Buspirone; Fluoxetine; Humans; Selegiline; Sleep; Trazodone	1992
Seizure associated with fluoxetine and adjuvant buspirone therapy. Journal of clinical psychopharmacology, 1992, Volume: 12, Issue:1 Topics: Adult; Buspirone; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder	1992
Treatment of social phobia with drugs other than benzodiazepines. The Journal of clinical psychiatry, 1991, Volume: 52 Suppl Topics: Adolescent; Atenolol; Benzamides; Buspirone; Child; Clinical Trials as Topic; Female; Fluoxetine; Humans; Male; Moclobemide; Phenelzine; Phobic Disorders; Placebos	1991
Fluoxetine potentiation by buspirone: three case histories. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1991, Volume: 36, Issue:10 Topics: Adult; Buspirone; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Trazodone; Tryptophan	1991
Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1991, Volume: 1 Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Drinking Behavior; Ethanol; Feeding Behavior; Fluoxetine; Male; Pindolol; Piperazines; Rats; Rats, Inbred Strains; Rats, Wistar; Scopolamine; Self Administration; Serotonin Receptor Agonists; Species Specificity; Verapamil	1991
Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder. The American journal of psychiatry, 1991, Volume: 148, Issue:11 Topics: Buspirone; Child, Preschool; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder	1991
Selective increase in carbohydrate intake by rats treated with 8-hydroxy-2-(di-n-propylamino)-tetraline or buspirone. Life sciences, 1990, Volume: 46, Issue:23 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Buspirone; Dietary Carbohydrates; Dose-Response Relationship, Drug; Drug Interactions; Eating; Fluoxetine; Food Preferences; Male; Naphthalenes; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes	1990
Paradoxical reaction to buspirone augmentation of fluoxetine. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:5 Topics: Adult; Buspirone; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Impulsive Behavior; Obsessive-Compulsive Disorder	1990
Interaction between fluoxetine and buspirone. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1990, Volume: 35, Issue:8 Topics: Adult; Akathisia, Drug-Induced; Anxiety Disorders; Buspirone; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Spasm	1990
Fluoxetine may antagonize the anxiolytic action of buspirone. Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:2 Topics: Adult; Anxiety; Buspirone; Drug Interactions; Fluoxetine; Humans; Male	1989
Fluoxetine, buspirone, myoclonus, and dystonia. The American journal of psychiatry, 1995, Volume: 152, Issue:11 Topics: Buspirone; Dystonia; Fluoxetine; Humans; Male; Middle Aged; Myoclonus	1995
The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:10 Topics: Adult; Buspirone; Depersonalization; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome	1995
Animal behavior case of the month. Periodic aggression toward the owner. Journal of the American Veterinary Medical Association, 1995, Mar-01, Volume: 206, Issue:5 Topics: Aggression; Animals; Animals, Domestic; Behavior Therapy; Buspirone; Combined Modality Therapy; Dogs; Female; Fluoxetine	1995
SSRI-associated nocturnal bruxism in four patients. The Journal of clinical psychiatry, 1993, Volume: 54, Issue:11 Topics: 1-Naphthylamine; Adult; Bruxism; Buspirone; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep	1993
Trichotillomania and body dysmorphic disorder. The Journal of clinical psychiatry, 1994, Volume: 55, Issue:1 Topics: Adult; Buspirone; Delusions; Drug Therapy, Combination; Fluoxetine; Humans; Male; Trazodone; Trichotillomania	1994
Euphoria with buspirone after fluoxetine treatment. The American journal of psychiatry, 1993, Volume: 150, Issue:1 Topics: Aged; Alzheimer Disease; Anxiety Disorders; Buspirone; Euphoria; Female; Fluoxetine; Humans; Male	1993
Obsessive-compulsive disorder, fluoxetine, and buspirone. The American journal of psychiatry, 1993, Volume: 150, Issue:3 Topics: Buspirone; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder	1993
Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference. Alcohol and alcoholism (Oxford, Oxfordshire), 1993, Volume: 28, Issue:2 Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Chlordiazepoxide; Citalopram; Dose-Response Relationship, Drug; Drinking; Fluoxetine; Male; Ondansetron; Rats; Receptors, Serotonin; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists	1993
Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission. Critical care medicine, 1996, Volume: 24, Issue:6 Topics: Alcohol Withdrawal Delirium; Buspirone; Clomipramine; Diagnosis, Differential; Drug Therapy, Combination; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Myoclonus; Obsessive-Compulsive Disorder; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome	1996
Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. Journal of neurochemistry, 1997, Volume: 68, Issue:3 Topics: Animals; Buspirone; Dopamine; Duloxetine Hydrochloride; Fluoxetine; Frontal Lobe; Male; Microdialysis; Norepinephrine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Thiophenes	1997
Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists. Neuropharmacology, 1997, Volume: 36, Issue:3 Topics: Animals; Buspirone; Cocaine; Discrimination, Psychological; Dose-Response Relationship, Drug; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists	1997
Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. European journal of pharmacology, 1998, Mar-12, Volume: 345, Issue:1 Topics: Animals; Buspirone; Cyclohexanes; Extracellular Space; Fluoxetine; Male; Microdialysis; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists	1998
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacology, 1998, Volume: 138, Issue:2 Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming	1998
An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat. Alcohol (Fayetteville, N.Y.), 1998, Volume: 16, Issue:3 Topics: Animals; Buspirone; Dose-Response Relationship, Drug; Ethanol; Female; Fenfluramine; Fluoxetine; Metergoline; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Ritanserin; Selective Serotonin Reuptake Inhibitors; Self Administration; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors	1998
Treatment of obsessive-compulsive disorder using clomipramine in a very old patient. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Buspirone; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Heart Diseases; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1999
Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions Neuroscience, 1999, Volume: 93, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; Buspirone; Chromatography, High Pressure Liquid; Dopamine; Dopamine Antagonists; Drug Interactions; Fluoxetine; Frontal Lobe; Locomotion; Male; Microdialysis; Neural Inhibition; Norepinephrine; Oxazoles; Piperazines; Pyridines; Raclopride; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists	1999
Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 10, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzimidazoles; Brain; Buspirone; Dose-Response Relationship, Drug; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists	1999
[Neuropharmacological analysis of participation of the serotoninergic system in hyperalgesia in neurotized rats]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2000, Volume: 86, Issue:2 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Fluoxetine; Hyperalgesia; Male; Mianserin; Neurotic Disorders; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists	2000
Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology, 2000, Jun-08, Volume: 39, Issue:8 Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Buspirone; Diazepam; Dose-Response Relationship, Drug; Female; Fluoxetine; Gene Deletion; Guinea Pigs; Imipramine; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Receptors, Neurokinin-1; Social Isolation; Stress, Psychological; Substance P; Tetrazoles; Vocalization, Animal	2000
Female sexual dysfunction and antidepressant use. The American journal of psychiatry, 2001, Volume: 158, Issue:2 Topics: Amantadine; Antidepressive Agents; Buspirone; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Meta-Analysis as Topic; Paroxetine; Personality Inventory; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome	2001
An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice. Behavioural pharmacology, 2001, Volume: 12, Issue:3 Topics: Animals; Anxiety; Arousal; Buspirone; Diazepam; Exploratory Behavior; Fluoxetine; Humans; Male; Mianserin; Mice; Mice, Inbred BALB C; Motor Activity; Quinolines; Receptors, Dopamine; Receptors, Neurotransmitter; Social Environment	2001
Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex. Neurochemistry international, 2002, Volume: 40, Issue:4 Topics: Animals; Buspirone; Chromatography, High Pressure Liquid; Dopamine; Drug Synergism; Fluoxetine; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Microdialysis; Nerve Tissue Proteins; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists	2002
Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury. Brain injury, 2002, Volume: 16, Issue:4 Topics: Adult; Anti-Anxiety Agents; Bipolar Disorder; Brain Injuries; Buspirone; Depression; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Ginkgo biloba; Humans; Hypericum; Phytotherapy; Plant Preparations; Selective Serotonin Reuptake Inhibitors	2002
Seed finding in golden hamsters: a potential animal model for screening anxiolytic drugs. Neuropsychobiology, 2002, Volume: 45, Issue:3 Topics: Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Appetitive Behavior; Behavior, Animal; Buspirone; Chlordiazepoxide; Clozapine; Cricetinae; Desipramine; Drug Evaluation, Preclinical; Fasting; Fluoxetine; Injections, Intraperitoneal; Male; Mesocricetus; Models, Animal; Stress, Psychological; Yohimbine	2002
Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. Molecular psychiatry, 2002, Volume: 7, Issue:5 Topics: Analysis of Variance; Animals; Bupropion; Buspirone; Colon; Corticotropin-Releasing Hormone; Diazepam; Dose-Response Relationship, Drug; Fluoxetine; Gastric Mucosa; Male; Mucins; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stomach Ulcer	2002
Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice. Psychopharmacology, 2003, Volume: 166, Issue:3 Topics: 5-Hydroxytryptophan; Analgesics; Animals; Buspirone; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Chloride; Central Nervous System Stimulants; Chelating Agents; Egtazic Acid; Female; Fluoxetine; Injections, Intraventricular; Mice; Nifedipine; Pain Measurement; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ryanodine; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists	2003
Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task. European journal of pharmacology, 2003, Sep-23, Volume: 477, Issue:3 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Buspirone; Conditioning, Operant; Cues; Discrimination Learning; Drug Administration Schedule; Fluoxetine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Memory, Short-Term; Rats; Reaction Time; Receptor, Serotonin, 5-HT1A	2003
The serotonergic system may be involved in the sleep-inducing action of oleamide in rats. Naunyn-Schmiedeberg's archives of pharmacology, 2003, Volume: 368, Issue:6 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Fenfluramine; Fluoxetine; Hypnotics and Sedatives; Male; Neural Pathways; Oleic Acids; Piperazines; Pyridines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sleep; Sleep, REM; Wakefulness	2003
The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques. Comparative medicine, 2005, Volume: 55, Issue:1 Topics: Animals; Behavior, Animal; Body Weight; Buspirone; Cerebrospinal Fluid; Fluoxetine; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Placebos; Random Allocation; Self-Injurious Behavior; Serotonin; Serotonin Receptor Agonists	2005
Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. Indian journal of experimental biology, 2005, Volume: 43, Issue:7 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antitussive Agents; Behavior, Animal; Buspirone; Central Nervous System; Dexfenfluramine; Dextromethorphan; Fluoxetine; Male; Propranolol; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists; Syndrome	2005
Co-administration of fluoxetine and WAY100635 improves short-term memory function. European journal of pharmacology, 2005, Oct-17, Volume: 522, Issue:1-3 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Buspirone; Drug Interactions; Fluoxetine; Male; Memory, Short-Term; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists	2005
Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. Psychopharmacology, 2006, Volume: 183, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Anti-Anxiety Agents; Buspirone; Fluoxetine; Male; Microinjections; Periaqueductal Gray; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists	2006
Pharmacological evaluation of the stress-induced social avoidance model of anxiety. Brain research bulletin, 2006, Mar-31, Volume: 69, Issue:2 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Haloperidol; Male; Models, Neurological; Motor Activity; Phobic Disorders; Piperazines; Rats; Rats, Wistar; Reproducibility of Results; Serotonin Receptor Agonists; Stress, Psychological	2006
Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition. Behavioural pharmacology, 2008, Volume: 19, Issue:3 Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Buspirone; Dose-Response Relationship, Drug; Electrophysiology; Fluoxetine; Hippocampus; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reinforcement Schedule; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists	2008
Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test. Arzneimittel-Forschung, 2010, Volume: 60, Issue:3 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Depression; Fluoxetine; Interferon-alpha; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxadiazoles; Piperazines; Pyridines; Quinoxalines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming	2010
Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. Journal of neurochemistry, 2011, Volume: 116, Issue:2 Topics: Animals; Brain; Buspirone; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Protein Binding; Protein Transport; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Plasma Membrane Transport Proteins; Social Behavior	2011
Use of buspirone and fluoxetine for breathing problems in Rett syndrome. Pediatric neurology, 2012, Volume: 46, Issue:3 Topics: Apnea; Buspirone; Child; Female; Fluoxetine; Humans; Hyperventilation; Rett Syndrome; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome	2012
Role of serotonin in zebrafish (Danio rerio) anxiety: relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models. Neuropharmacology, 2013, Volume: 71 Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Buspirone; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Fluid; Fenclonine; Fluoxetine; Hyperkinesis; Nerve Tissue Proteins; Neurons; Piperazines; Piperidones; Protein Isoforms; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Spiro Compounds; Zebrafish	2013
Effect of Chronic Administration of Buspirone and Fluoxetine on Inflammatory Cytokines in 6-Hydroxydopamine-lesioned Rats. Drug research, 2015, Volume: 65, Issue:8 Topics: Animals; Buspirone; Cerebrospinal Fluid; Fluoxetine; Interleukin-1beta; Interleukin-6; Male; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Tumor Necrosis Factor-alpha	2015
Dual role of serotonin in the acquisition and extinction of reward-driven learning: involvement of 5-HT1A, 5-HT2A and 5-HT3 receptors. Behavioural brain research, 2015, Jan-15, Volume: 277 Topics: Animals; Buspirone; Fluoxetine; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT3; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists	2015
Dose dependent effects of serotonergic agents on anxiety. Acta physiologica Hungarica, 2014, Volume: 101, Issue:4 Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Buspirone; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Male; Maze Learning; Motor Activity; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Time Factors	2014
The side-by-side exploratory test: a simple automated protocol for the evaluation of adult zebrafish behavior simultaneously with social interaction. Behavioural pharmacology, 2015, Volume: 26, Issue:7 Spec No Topics: Animals; Bromazepam; Buspirone; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Exploratory Behavior; Fear; Female; Fluoxetine; Male; Pattern Recognition, Automated; Psychological Tests; Psychotropic Drugs; Social Behavior; Software; Stress, Psychological; Vision, Ocular; Zebrafish	2015
Buspirone in the Treatment of Fluoxetine-Induced Sleep Bruxism. Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:8 Topics: Buspirone; Child; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sleep Bruxism	2016
Prenatal Stimulation of 5-HT Bulletin of experimental biology and medicine, 2019, Volume: 166, Issue:3 Topics: Adaptation, Psychological; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Buspirone; Depression; Drug Administration Schedule; Drug Combinations; Female; Fetus; Fluoxetine; Immobilization; Male; Pain; Pain Measurement; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Stress, Psychological	2019
Animal Behavior Case of the Month. Journal of the American Veterinary Medical Association, 2019, Feb-15, Volume: 254, Issue:4 Topics: Aggression; Animals; Behavior Therapy; Behavior, Animal; Buspirone; Clonidine; Dogs; Female; Fluoxetine	2019
The effect of acute and repeated administration of buspirone, 8-OHDPAT and fluoxetine on haloperidol-induced extrapyramidal symptoms. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2019, Volume: 21, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Catalepsy; Fluoxetine; Haloperidol; Male; Pyramidal Cells; Rats; Rats, Wistar	2019
Effects of Stress Exposure during Adolescent Period on Inflammatory Pain Response, Psychoemotional Behavior, and Action of Antidepressants in Prenatally Stressed Adult Male Rats. Bulletin of experimental biology and medicine, 2020, Volume: 169, Issue:3 Topics: Animals; Antidepressive Agents; Behavior, Animal; Buspirone; Female; Fluoxetine; Inflammation; Male; Pain; Pregnancy; Rats; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Stress, Psychological; Swimming	2020
Neonatal pain modulates in adolescent rats the antinociceptive effects of fluoxetine and buspirone administrated to their depressive dams during gestation. Canadian journal of physiology and pharmacology, 2021, Volume: 99, Issue:6 Topics: Animals; Buspirone; Female; Fluoxetine; Male; Pain; Pregnancy; Rats	2021
Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:2 Topics: Animals; Buspirone; Cervical Cord; Electromyography; Evoked Potentials, Motor; Female; Fluoxetine; Forelimb; Hand Strength; Rats; Rats, Long-Evans; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Spinal Cord Injuries	2021
Buspirone, a 5-HT1A agonist attenuates social isolation-induced behavior deficits in rats: a comparative study with fluoxetine. Behavioural pharmacology, 2022, 08-01, Volume: 33, Issue:5 Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Buspirone; Fluoxetine; Humans; Hydrocortisone; Male; Rats; Rats, Wistar; Serotonin 5-HT1 Receptor Agonists; Social Isolation	2022
Methodological approach: using a within-subjects design in the marble burying assay. Behavioural pharmacology, 2023, 12-01, Volume: 34, Issue:8 Topics: Animals; Behavior, Animal; Buspirone; Calcium Carbonate; Disease Models, Animal; Female; Fluoxetine; Humans; Ketamine; Male; Mice	2023